A.J. WELLS & SONS LIMITED

Company number 03809371 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

1. Financial Health Score: B (Provisional - Pending Full Lab Results)

Explanation: I am awarding a provisional grade of B because the patient exhibits excellent structural and compliance health. A.J. Wells & Sons Limited has a strong, 25-year "heartbeat" and shows no external symptoms of distress. However, because the quantitative "blood work" (the actual financial figures like turnover, assets, and liabilities) is missing from this chart, a definitive grade cannot be issued. A full set of filed accounts is required to check the cholesterol levels (debt) and blood pressure (cash flow).


2. Key Vital Signs

  • Corporate Pulse (Company Age & Status): Strong. Incorporated in 1999, this business has a 25-year operating history. Surviving multiple economic cycles in the manufacturing sector indicates a resilient constitution. The status is "Active," meaning the heart is currently beating and the business is operational.
  • Regulatory Blood Pressure (Filing Compliance): Healthy. Both the annual accounts and the confirmation statement are up to date, with no overdue flags. This indicates a healthy regime of administrative discipline, drastically reducing the risk of regulatory penalties or forced strike-off.
  • Genetic Makeup (Ownership & Control): Stable but concentrated. The PSC (Persons with Significant Control) register shows Mr. Paul Wells and Mr. John Wells each owning between 25% and 50% of shares. The board is heavily populated by the Wells family. This familial alignment often means a unified long-term vision, but it can also represent a genetic vulnerability if key "organs" (family members) become unavailable.
  • Financial Blood Work (Quantitative Metrics): Awaiting results. The share capital is merely £64, which is a historical artifact from incorporation rather than a measure of current wealth. Without the P&L reserve, current assets, and liabilities, we cannot measure the company's actual financial muscle or liquidity.

3. Diagnosis

Based on the available qualitative data, A.J. Wells & Sons Limited presents as a mature, stable, family-owned manufacturing entity. The immediate change of its name from "RP 221 LIMITED" shortly after birth in 1999 shows a planned, intentional start to life, rather than a speculative venture.

The fact that the company files "Full" accounts (rather than micro or small abbreviated accounts) tells us something critical about its size: it has outgrown the smaller filing thresholds, meaning it likely has a healthy body mass (turnover or balance sheet totals exceeding the small company limits).

There are no visible symptoms of distress—no liquidation, no administration, and no disqualifications against its directors. The £64 share capital is not a symptom of emaciation; rather, it is a common "birthmark" of older UK companies, representing the original nominal share issue before retained profits (the P&L reserve) did the heavy lifting over the last quarter-century.


4. Recommendations

To move from a provisional to a definitive health grade, the following steps are recommended:

  1. Draw the Full Blood Panel: Obtain the last few years of full filed accounts from Companies House to assess working capital (current assets vs. current liabilities) and profitability. You need to ensure the cash flow arteries aren't restricted.
  2. Succession Planning (Corporate Estate Planning): With an aging family board and multiple generations implied by the officer list, it is vital to have a robust succession plan. Ensure there is "key-person insurance" and clear governance to prevent corporate cardiac arrest if a founding family member retires or becomes incapacitated.
  3. Cardiovascular Exercise (Growth & Liquidity): For a 25-year-old manufacturing firm, ensure that capital expenditures (fixed assets) are keeping pace with industry standards. Aging machinery can lead to operational clots; reinvestment in equipment is the corporate equivalent of keeping the cardiovascular system healthy.

Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 4 August 2026